PharmaCyte Biotech (PMCB) Share-based Compensation (2009 - 2026)
PharmaCyte Biotech (PMCB) posted Share-based Compensation of $892,500 for FY2026 (year ended Apr 30, 2026).
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Share-based Compensation (2009 - 2026) Analysis & Trends
Since FY2011, PharmaCyte Biotech has reported Share-based Compensation for 15 fiscal years.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 35.7% (FY2021 to FY2026).
- The FY2026 figure stands as the highest annual Share-based Compensation since FY2014.
- Business Quant data shows PMCB's Share-based Compensation at $674,693 in FY2024, $7,334 in FY2023 (-79.0%) and $34,846 in FY2022 (-82.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2026 | 771,516.00 |
| Oct 31, 2025 | 60,492.00 |
| Jul 31, 2025 | 60,492.00 |
| Jan 31, 2025 | -341,832.00 |
| Oct 31, 2024 | 119,155.00 |
| Jul 31, 2024 | 222,677.00 |
| Jan 31, 2024 | 674,693.00 |
| Oct 31, 2023 | -913,640.00 |
| Jul 31, 2023 | 913,640.00 |
| Jan 31, 2023 | 667.00 |
| Oct 31, 2022 | 3,917.00 |
| Jul 31, 2022 | 2,750.00 |
| Apr 30, 2022 | 3,073.00 |
| Jan 31, 2022 | 2,442.00 |
| Oct 31, 2021 | 4,566.00 |
| Jul 31, 2021 | 24,765.00 |
| Apr 30, 2021 | 11,055.00 |
| Jan 31, 2021 | 48,566.00 |
| Oct 31, 2020 | 67,320.00 |
| Jul 31, 2020 | 67,320.00 |
API Access
PharmaCyte Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();